Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
Mittendorf, E.A., Clifton, G.T., Holmes, J.P., Schneble, E., van Echo, D., Ponniah, S., Peoples, G.E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Which threshold for ER positivity? a retrospective study based on 9639 patients
Yi, M., Huo, L., Koenig, K.B., Mittendorf, E.A., Meric-Bernstam, F., Kuerer, H.M., Bedrosian, I., Buzdar, A.U., Symmans, W.F., Crow, J.R., Bender, M., Shah, R.R., Hortobagyi, G.N., Hunt, K.K.
Published in Annals of oncology (01.05.2014)
Published in Annals of oncology (01.05.2014)
Get full text
Journal Article
Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer
Harano, K., Lei, X., Gonzalez-Angulo, A. M., Murthy, R. K., Valero, V., Mittendorf, E. A., Ueno, N. T., Hortobagyi, G. N., Chavez-MacGregor, M.
Published in Breast cancer research and treatment (01.09.2016)
Published in Breast cancer research and treatment (01.09.2016)
Get full text
Journal Article
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
Kim, M.M., Allen, P., Gonzalez-Angulo, A.M., Woodward, W.A., Meric-Bernstam, F., Buzdar, A.U., Hunt, K.K., Kuerer, H.M., Litton, J.K., Hortobagyi, G.N., Buchholz, T.A., Mittendorf, E.A.
Published in Annals of oncology (01.08.2013)
Published in Annals of oncology (01.08.2013)
Get full text
Journal Article
Comparison of clinicopathologic features and survival in young American women aged 18–39 years in different ethnic groups with breast cancer
Liu, P, Li, X, Mittendorf, E A, Li, J, Du, X L, He, J, Ren, Y, Yang, J, Hunt, K K, Yi, M
Published in British journal of cancer (03.09.2013)
Published in British journal of cancer (03.09.2013)
Get full text
Journal Article
A novel interaction between HER2 neu and cyclin E in breast cancer
Mittendorf, E A, Liu, Y, Tucker, S L, McKenzie, T, Qiao, N, Akli, S, Biernacka, A, Liu, Y, Meijer, L, Keyomarsi, K, Hunt, K K
Published in Oncogene (08.07.2010)
Published in Oncogene (08.07.2010)
Get full text
Journal Article
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
Alatrash, G, Garber, H R, Zhang, M, Sukhumalchandra, P, Qiu, Y, Jakher, H, Perakis, A A, Becker, L, Yoo, S Y, Dwyer, K C, Coombes, K, Talukder, A H, John, L S St, Senyukov, V, Lee, D A, Sergeeva, A, He, H, Ma, Q, Armistead, P M, Roszik, J, Mittendorf, E A, Molldrem, J J, Hawke, D, Lizee, G, Kornblau, S M
Published in Leukemia (01.01.2017)
Published in Leukemia (01.01.2017)
Get full text
Journal Article
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
Antonarelli, G., Corti, C., Tarantino, P., Ascione, L., Cortes, J., Romero, P., Mittendorf, E.A., Disis, M.L., Curigliano, G.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib
Tarantino, P., Jin, Q., Mittendorf, E.A., King, T.A., Curigliano, G., Tolaney, S.M.
Published in Annals of oncology (01.08.2022)
Published in Annals of oncology (01.08.2022)
Get full text
Journal Article
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
Spring, L.M., Tolaney, S.M., Fell, G., Bossuyt, V., Abelman, R.O., Wu, B., Maheswaran, S., Trippa, L., Comander, A., Mulvey, T., McLaughlin, S., Ryan, P., Ryan, L., Abraham, E., Rosenstock, A., Garrido-Castro, A.C., Lynce, F., Moy, B., Isakoff, S.J., Tung, N., Mittendorf, E.A., Ellisen, L.W., Bardia, A.
Published in Annals of oncology (01.03.2024)
Published in Annals of oncology (01.03.2024)
Get full text
Journal Article
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence
Mittendorf, E.A., Ardavanis, A., Symanowski, J., Murray, J.L., Shumway, N.M., Litton, J.K., Hale, D.F., Perez, S.A., Anastasopoulou, E.A., Pistamaltzian, N.F., Ponniah, S., Baxevanis, C.N., von Hofe, E., Papamichail, M., Peoples, G.E.
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Villacampa, G., Tung, N.M., Pernas, S., Paré, L., Bueno-Muiño, C., Echavarría, I., López-Tarruella, S., Roche-Molina, M., del Monte-Millán, M., Marín-Aguilera, M., Brasó-Maristany, F., Waks, A.G., Pascual, T., Martínez-Sáez, O., Vivancos, A., Conte, P.F., Guarneri, V., Vittoria Dieci, M., Griguolo, G., Cortés, J., Llombart-Cussac, A., Muñoz, M., Vidal, M., Adamo, B., Wolff, A.C., DeMichele, A., Villagrasa, P., Parker, J.S., Perou, C.M., Fernandez-Martinez, A., Carey, L.A., Mittendorf, E.A., Martín, M., Prat, A., Tolaney, S.M.
Published in Annals of oncology (01.09.2023)
Published in Annals of oncology (01.09.2023)
Get full text
Journal Article
The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial
Barroso-Sousa, R., Barry, W.T., Guo, H., Dillon, D., Tan, Y.B., Fuhrman, K., Osmani, W., Getz, A., Baltay, M., Dang, C., Yardley, D., Moy, B., Marcom, P.K., Mittendorf, E.A., Krop, I.E., Winer, E.P., Tolaney, S.M.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins
Tevis, S. E., Neuman, H. B., Mittendorf, E. A., Kuerer, H. M., Bedrosian, I., DeSnyder, S. M., Thompson, A. M., Black, D. M., Scoggins, M. E., Sahin, A. A., Hunt, K. K., Caudle, A. S.
Published in Annals of surgical oncology (01.10.2018)
Published in Annals of surgical oncology (01.10.2018)
Get full text
Journal Article
OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients
Tevis, S. E., Bassett, R., Bedrosian, I., Barcenas, C. H., Black, D. M., Caudle, A. S., DeSnyder, S. M., Fitzsullivan, E., Hunt, K. K., Kuerer, H. M., Lucci, A., Meric-Bernstam, F., Mittendorf, E. A., Park, K., Teshome, M., Thompson, A. M., Hwang, R. F.
Published in Annals of surgical oncology (01.03.2019)
Published in Annals of surgical oncology (01.03.2019)
Get full text
Journal Article
Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
Hall, C., Hess, K.R., Ravenberg, L., Clayborn, A., Rauch, G.M., Candelaria, R., Mittendorf, E.A., Moulder, S.L., Thompson, A., Lucci, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Pre-specified interim analysis of a randomized phase IIb trial of trastuzumab + nelipeptimut-S (NeuVax) vs trastuzumab for the prevention of recurrence demonstrates benefit in triple negative (HER2 low-expressing) breast cancer patients
Hale, D.F., Mittendorf, E.A., Brown, T.A., Clifton, G.T., Vreeland, T.J., Myers, J., Peace, K., Jackson, D., Greene, J., Holmes, J., Peoples, G.E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Neoadjuvant trial of nab-paclitaxel and atezolizumab (Atezo), a PD-L1 inhibitor, in patients (pts) with chemo-insensitive triple negative breast cancer (TNBC)
Litton, J.K., Moulder, S.L., Hess, K.R., Damodaran, S., Rauch, G.M., Candelaria, R., Adrada, B.E., Symmans, F., Murthy, R.K., Helgason, T., Clayborn, A., Prabhakaran, S., Valero, V., Thompson, A.M., Mittendorf, E.A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article